My Companies
Notification
Account
Log Out
Login
Board approved Rs1,279.35cr rights issue of 1,70,58,082 shares at Rs750 each in 2-for-21 ratio, record date Oct 1, 2026, open Oct 12-22 with renunciation till Oct 16. Context: sets pending price, ratio and record-date terms.
Natco Pharma Fixes ₹750 Price For ₹1,279 Crore 2:21 Rights Issue
Natco Pharma Proposes ₹1,300 Crore Rights Issue For Debt Repayment
Natco Pharma Approves Rights Issue Of Up To ₹1,300 Crore
Natco Pharma Explores ₹2,000 Crore Capital Raise Alongside Q1 Results
Natco Pharma Gets US FDA Tentative Approval For Olaparib Generic